| Wednesday, June 25, 2025 Abstract Session 53 – CRS – Outcome Assessment 3 ROOM 12 (G11) | Level +1 11:35h – 12:50h ABSTRACTS |
| Chair: Nora Haloob |
| 4032 – Defining Mepolizumab biological criteria response in chronic rhinosinusitis with nasal polyps patients after two years of treatment |
| Domínguez Sosa María Sandra |
| 4397 – Correlation of sino-nasal outcome test and nasal polyp score in dupilumab-treated chronic rhinosinusitis with nasal polyps |
| Mauthe Tina |
| 4405 – Improvement of Modified Lund-Kennedy endoscopic score in patient with severe type-2 chronic rhinosinusitis with nasal polyps (CRSwNP) treated with anti-IL4/IL-13 monoclonal antibodies related to the extent of previous endoscopic sinus surgery |
| Giorli Alessia |
| 4407 – Obesity and Its Impact on Endoscopic Sinus Surgery Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps |
| Chaushu Hen |
| 4436 – BEAMER: Development of a model for disease-agnostic adherence improvement – a multidisciplinary EU project integrating chronic rhinosinusitis (CRS) |
| Nicole Sander |
| 4445 – Nasalance and sinonasal volume changes in patients underwent Endoscopic Modified Lothrop Procedures (EMLP) |
| Wang Ying-Piao |
| 4451 – Age-related subjective outcome and biological treatment need after surgery for chronic rhinosinusitis with nasal polyposis type 2. |
| Zoabi Tareq |
